common

Perma-Pipe International Holdings, Inc. Announces First Quarter Fiscal 2025 Financial Results

The Company generated net sales of $46.7 million compared to $34.3 million in the first quarter of 2024 Income before…

3 weeks ago

Draganfly Announces Closing of US$13.75 Million Public Offering

Saskatoon, SK., June 12, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”),…

3 weeks ago

HYCROFT ANNOUNCES PRICING AND UPSIZING OF PUBLIC OFFERING OF UNITS

WINNEMUCCA, Nev., June 12, 2025 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft" or the "Company") is pleased to…

3 weeks ago

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025 Rutherford, NJ, June…

3 weeks ago

Hycroft Announces Public Offering of Units

WINNEMUCCA, Nev., June 11, 2025 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft" or the "Company") is pleased to…

3 weeks ago

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 09, 2025 16:05 ET  | Source: Vera Therapeutics BRISBANE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc.…

3 weeks ago

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical…

3 weeks ago

Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full…

4 weeks ago

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 06, 2025 16:01 ET  | Source: Replimune Group Inc WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group,…

4 weeks ago

Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million

VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) --  Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”),…

4 weeks ago